Criteria for evaluation of disease extent by 123I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Criteria for evaluation of disease extent by 123I-metaiodobenzylguanidine scans in neuroblastoma: a report for the International Neuroblastoma Risk Group (INRG) Task Force
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 102, Issue 9, Pages 1319-1326
Publisher
Springer Nature
Online
2010-04-28
DOI
10.1038/sj.bjc.6605621
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- International consensus for neuroblastoma molecular diagnostics: report from the International Neuroblastoma Risk Group (INRG) Biology Committee
- (2009) P F Ambros et al. BRITISH JOURNAL OF CANCER
- Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: A review
- (2009) Marco Tuccori et al. CLINICAL THERAPEUTICS
- Sensitivity of Surveillance Studies for Detecting Asymptomatic and Unsuspected Relapse of High-Risk Neuroblastoma
- (2009) Brian H. Kushner et al. JOURNAL OF CLINICAL ONCOLOGY
- Iodine-131—Metaiodobenzylguanidine Double Infusion With Autologous Stem-Cell Rescue for Neuroblastoma: A New Approaches to Neuroblastoma Therapy Phase I Study
- (2009) Katherine K. Matthay et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of Iodine-123 Metaiodobenzylguanidine (MIBG) Scan and [18F]Fluorodeoxyglucose Positron Emission Tomography to Evaluate Response After Iodine-131 MIBG Therapy for Relapsed Neuroblastoma
- (2009) Denah R. Taggart et al. JOURNAL OF CLINICAL ONCOLOGY
- Excellent Outcome With Reduced Treatment for Infants With Disseminated Neuroblastoma WithoutMYCNGene Amplification
- (2009) Bruno De Bernardi et al. JOURNAL OF CLINICAL ONCOLOGY
- 123I-MIBG Scintigraphy and 18F-FDG PET in Neuroblastoma
- (2009) S. E. Sharp et al. JOURNAL OF NUCLEAR MEDICINE
- 123I-mIBG scintigraphy in patients with known or suspected neuroblastoma: Results from a prospective multicenter trial
- (2009) Terry A. Vik et al. PEDIATRIC BLOOD & CANCER
- Added Value of SPECT/CT for Correlation of MIBG Scintigraphy and Diagnostic CT in Neuroblastoma and Pheochromocytoma
- (2008) Katia Rozovsky et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Pharmacokinetic/Pharmacodynamic Modelling of Venlafaxine
- (2008) Andreas Lindauer et al. CLINICAL PHARMACOKINETICS
- Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4 neuroblastoma patients over 1 year of age
- (2008) Jan de Kraker et al. EUROPEAN JOURNAL OF CANCER
- The prognostic impact of functional imaging with 123I-mIBG in patients with stage 4 neuroblastoma >1 year of age on a high-risk treatment protocol: Results of the German Neuroblastoma Trial NB97
- (2008) Matthias Schmidt et al. EUROPEAN JOURNAL OF CANCER
- FDG PET/CT findings in secondary hyperparathyroidism not mimicking multiple bone metastases
- (2008) Elise Le Stanc et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- EANM procedure guidelines for 131I-meta-iodobenzylguanidine (131I-mIBG) therapy
- (2008) Francesco Giammarile et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Localized Infant Neuroblastomas Often Show Spontaneous Regression: Results of the Prospective Trials NB95-S and NB97
- (2008) Barbara Hero et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report
- (2008) Tom Monclair et al. JOURNAL OF CLINICAL ONCOLOGY
- The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report
- (2008) Susan L. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
- Radiolabeled metaiodobenzylguanidine for the treatment of neuroblastoma
- (2008) Steven G. DuBois et al. NUCLEAR MEDICINE AND BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now